- Events
30/04/2025
EASL 2025 - Supporting Liver Disease Innovation
We are pleased to announce that TransCure bioServices will be attending the EASL Congress 2025, taking place from May 7 to 10 in Amsterdam, Netherlands.
The EASL Congress is one of the world’s leading events dedicated to liver disease research, bringing together clinicians, researchers, and industry experts to share cutting-edge science and therapeutic advances.
At TransCure bioServices, we are proud to advance liver disease research with our cutting-edge humanized liver and double humanized mouse models-featuring both human liver and immune system engraftment. These models enable robust preclinical evaluation of therapies for hepatitis, MASH, fibrosis, gene editing and other complex liver-related conditions.
Whether you’re developing antiviral strategies, exploring immune-mediated inflammation, or targeting metabolic dysfunction, our platforms offer exceptional translational relevance—bringing your therapeutic innovations one step closer to the clinic.
📅 Let’s connect in Amsterdam to explore how our preclinical solutions can support your liver disease programs.